Side-by-side comparison of AI visibility scores, market position, and capabilities
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Singapore YC healthcare worker super app with 150K+ verified nurses for peer advice, jobs, and credential management at $1.8M ARR Jul 2025; $1.38M Flare Capital seed with Penn Medicine/MedPro partnerships competing with Doximity for allied health professionals.
Adni is a Singapore-headquartered AI-powered super app for healthcare workers — backed by Y Combinator with $1.38 million raised including a $1.25 million seed round in May 2022 from YC, Flare Capital Partners, and Fresco Capital — providing 150,000+ verified nurses and allied healthcare professionals with a unified platform for anonymous peer advice sharing, job discovery, credential management (universal professional profile storing licenses, certifications, and continuing education records), equipment procurement, and community resources, generating $1.8 million in annual revenue as of July 2025 with approximately 32 employees across Asia and North America. Adni partners with leading healthcare organizations including Penn Medicine, MedPro, and PRN Healthcare to provide nurses and allied health workers with the professional tools that their clinical training institutions and hospital employers don't provide.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.